Patent Baristas

Without going into how much fun it is to look like a geriatric smoker walking around with an attractive nose cannula, there seems to be more and more interest in breathing in oxygen (at least air that has more oxygen than normal). There was even an oxygen bar at BIO this year. Now, the air […]

ZymoGenetics, Inc. filed an infringement suit against Bristol-Myers Squibb over its patents related to fusion protein technology. The lawsuit, ZymoGenetics, Inc. v. Bristol-Myers Squibb Co., et al., District Court of Delaware, is for injunctive relief and damages over infringement, contributory infringement and/or inducement of infringement of US Patent Nos. 5,843,725 and 6,018,026. The ‘026 Patent […]

In Amgen Inc., v. Hoechst Marion Roussel, Inc. (Now Aventis) and Transkaryotic Therapies, Inc., (05-1157), the Court of Appeals for the Federal Circuit affirmed a District Court’s decision that Transkaryotic Therapies Inc. (TKT) and Aventis Pharmaceuticals Inc. infringe Amgen’s erythropoietin (EPO) patent estate. The court’s decision upheld the validity of two of Amgen’s EPO patents […]

Sanofi-Aventis SA and Bristol-Myers Squibb filed for a preliminary injunction against Apotex Inc . to stop sales of a generic version of Plavix® (clopidogrel bisulfate). The companies are seeking an immediate halt on the sale of Apotex’ generic drug as well as a recall of drug already shipped. In the filing, the companies cited four […]

In Pennington Seed et al. v. Produce Exchange No. 299 et al. (05-1440), the Federal Circuit affirmed that claims against the University of Arkansas for infringement of a patent were barred by the Eleventh Amendment to the United States Constitution. Pennington filed suit against the University of Arkansas for infringement and conversion of U.S. Patent […]

We’ve said that nanotech is the next big thing in biotech. Now, the U.S. Food and Drug Administration has formed an internal task force to focus on the use of nanotechnology materials in drugs, medical instruments, and other products regulated by the agency. The new task force is charged with determining regulatory approaches that encourage […]

Apotex Inc. must be confident the patent on Plavix will be held invalid. In a gutsy move for a generic drug maker, Apotex (the Welterweight from Winnipeg) started shipping a generic copy of the blood thinner Plavix in the U.S., ahead of a likely patent infringement trial. A New York judge has denied a request […]

Like a bad penny, the Bayer AG And Bayer Corporation v. Housey Pharmaceuticals, Inc. case just keeps turning up. This time, the Court of Appeals for the Federal Circuit (06-1083) upheld a finding of inequitable conduct after vacating the earlier finding and remanding the case to give the district court an opportunity to provide additional […]